ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001237.1|Thiolactomycin_1 # 1 # 2811 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.759	BGC0001237.1|Thiolactomycin_1 	1	2811	-	Loose	1000	111.694	almE	24.89	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAACTCTGTGCCTGAGTCCGCCTGGACGGTGCCCGCGTGGACCGGGACCGCCGCCGCCCTCCCGGCGGTGGCCACCGACCCCGACCCGGTCGCCGCCCTCCCTTCCGACTCCCTGCTTCACCTGGCCTTCCTCGACCGGGCCGCCGAGACCCCGGACGCCGTGGCCGTCGTGGCCGCCGACCGGACCCTGACGTATGCCGAGCTGGCCAACGAGTCCGCCCGGCTAGCCGGCCTGCTCGCGGCCCGCGGCCTGGGCTGCGAAGCGCTCGTCGCCGTGGTGATGGAGAAGGGCTGGGAGCAGGTCGTGGCCTGCCTCGGCGTCCTGCGCGCCGGCGCCGCGTACGTCCCCGTGGACCCGCAGTGGCCGGCCCGCCGGCTGGCCGACGTGCTCGGTGCCGCCGGCATCACCGAGGCACTCACCCAGCCCAACCTCGTCGAGACTGTGGCCTGGCCCGAGGGCGTCGCGGCCACCGCGGTCGCGGCCCCCGCCGCGGACCTTTCGGCCGGCCCCGCCCCCGCGGCGCCGGCCGTGGACATCGCACCCGGCGACCTCGCGTACGTCATCTACACCTCCGGCTCCACCGGCATGCCCAAGGGCGTGATGATCGAACACGGGCCGGCGGTCAACACGGTCCGGGACGTCAACCGTGAGCTGGGCTGCGCGCCCGAGGACCGGGTGCTGGCCCTGTCGGCGCTCAACTTCGACCTCTCCGTCTACGACCTCTTCGGCCCCCTGTCGGCCGGCGGCGCGGTGGTGCTGCCCGCACCCGGCGACGCCCGCGAGCCCGGCGCCTGGCTGCGGCTCGCGACCGCGGCCGGGGTCACCCTCTGGAACAGCGTGCCGGCCCTGATGGCCATGTTCACCGAGTACGTCCGCACTGCCCCGCCGGCGCCCCTGCCGCCGCTGCGCGCGGTGCTGATGAGCGGCGACTGGATCCCGGTCGGCCTGCCCGGTGAGATCCGGGAGCTGTTCCCCGAGGCCCGCCAGTGGTCCCTCGGCGGCGCCACCGAGGCCTCCATCTGGTCCATCTGGCACCCCATCACGCCCGCGGACGCCGAACTCGCCTCGATCCCGTACGGCCGGTCGATGAGCGGCCAGCACGTGTACGTCGGCGACGGGATGATGCGGCCCCGGCCCTGCTGGGTGCCCGGTGAGATCCTCATCGCCGGCGTCGGCCTGGCCCGCGGCTACCTCGGCGACGCCGAGCGCACCGCGCGCAGCTTCGTCACCGATCCGGCCACCAGCGCCCGCCGCTACCGGACCGGCGACTGGGGGCGCCTCCTGCCCAGCGGCGAGATCGAGTTCCTGGGGCGCGAGGACATGCAGGTCAAGGTCGGCGGCCACCGAATCGAACTCGGCGACGTCGAGGCCGCGTTGCTGGCCTGCCCGGGTGTGCGGGGCGCGGTGGCCGACGTCCGGGGTGGCCGGCACCGCACCCGGCTCACCGCCCAGGTGCTGCTGGAGCCCGGCGCCGGTCACTCGGCCGAGGACGTGCGGGCGCTGCTGGCCGAGCGGGTGCCGTCGTACCTGGTGCCCACGTCCGTCACGGTCCGGGACGAGTTCCCGCTGACCCCGAACGGCAAGGTCGACCGCAAGGCCCTCGCCGCCCTCGCCGCCCGCACCGACGAGGCTGCCGCCGAGCACGTGGTCGAGCATCCCGCGGATGCCGATGAGGAGCTGCTCCTCGGCATCTGGCGCGGCTTCTTCACGGACCCGGCCCCGCGCCCAGGGCAGGACGTCGCGGGCGGTGCCGGCGACGTGGCCACGGACCGGCCCGCCGACGGTGCCGGCCACCGGCCCCCGCCGTCGTCCTGCGGCACGCACCTGTCCGTCACGGACAACTTCTTCGAGCTGGGCGGCGATTCGCTGCGCGCGGTACGCCTGATGTCCGTCCTGCGCCGGGAGACCGGTGTGGAACTGCCGGTGTCCGCCCTCTTCGGCGCGCCCACCGTGCGGACCCTGGCCCGCCGGCTGCGCGAGGCCCGCGAAACGGCCACCCGGGACGGCTTCGACCGGCCGGTCGTCGTCCCCGTGCGCACCACGGGTGACGCGGTTCCGCTGGTCTTCGCCCACCCGGTGGGCGGCGACGTGCTGTGCTACTCGGAGCTGGCCCGCGAGCTCGGCGCGGACCAGCCGTTCTACGCCCTCCAGTCGCCCGACCACGACGGCCGGGCGCCCGGCTTCGCCGAGCTGGTCACCCATTACGCGCAGGCCGTCCTGGACGAGGTGCCGGGCCGTCGGTACCGGCTGGGCGGCTGGTCGATGGGGGCGGTGCTGGCACTGGAGCTGGCCCGGGAACTGACCGCGCGGGGCTGCGTGGTGGACCTGGTGGCGGCCGTCGACGTCCTGGAGACCCCCCAGGACCTGGCCCGCGCCGAGATCAGCCGCGACCGGCTGCTCGGCTGGCTGGCCCGCGACCTCGCGGGCCTGACCGGCGGCGTCCGGCCGGTCCCGCCGGGCCCGTTCGAGACCCTGGAGGAGCTGTACGAGGCCGTGCGCGGCGCCGGGATCCTGCCGGCGGACATCGCGCCGGCGGAGTTCGCGTCCCTGTACGGGCGCTTCGAGGCGAACGCGCAGGCGCTGTGTGGCTATCGTCCCGGCGGGCCCCTCACCGGCACGGCGGTGCACTTCCTGCAGGCCGAGGCGGGCGGCGGTCCGGCGGCCGCCGAGGGCTGGCGCCCGCTGTGCGCGGGCGGTTTCACGCTCACCGAGGTCCCCGGCGACCACTACACCGTCCTGAAGGGCCCCGGCGCCCGAACGGTCGCCACCCACCTCCGCGCCCTCCTGACGACCCCCACCCCCGCCTGA	MNSVPESAWTVPAWTGTAAALPAVATDPDPVAALPSDSLLHLAFLDRAAETPDAVAVVAADRTLTYAELANESARLAGLLAARGLGCEALVAVVMEKGWEQVVACLGVLRAGAAYVPVDPQWPARRLADVLGAAGITEALTQPNLVETVAWPEGVAATAVAAPAADLSAGPAPAAPAVDIAPGDLAYVIYTSGSTGMPKGVMIEHGPAVNTVRDVNRELGCAPEDRVLALSALNFDLSVYDLFGPLSAGGAVVLPAPGDAREPGAWLRLATAAGVTLWNSVPALMAMFTEYVRTAPPAPLPPLRAVLMSGDWIPVGLPGEIRELFPEARQWSLGGATEASIWSIWHPITPADAELASIPYGRSMSGQHVYVGDGMMRPRPCWVPGEILIAGVGLARGYLGDAERTARSFVTDPATSARRYRTGDWGRLLPSGEIEFLGREDMQVKVGGHRIELGDVEAALLACPGVRGAVADVRGGRHRTRLTAQVLLEPGAGHSAEDVRALLAERVPSYLVPTSVTVRDEFPLTPNGKVDRKALAALAARTDEAAAEHVVEHPADADEELLLGIWRGFFTDPAPRPGQDVAGGAGDVATDRPADGAGHRPPPSSCGTHLSVTDNFFELGGDSLRAVRLMSVLRRETGVELPVSALFGAPTVRTLARRLREARETATRDGFDRPVVVPVRTTGDAVPLVFAHPVGGDVLCYSELARELGADQPFYALQSPDHDGRAPGFAELVTHYAQAVLDEVPGRRYRLGGWSMGAVLALELARELTARGCVVDLVAAVDVLETPQDLARAEISRDRLLGWLARDLAGLTGGVRPVPPGPFETLEELYEAVRGAGILPADIAPAEFASLYGRFEANAQALCGYRPGGPLTGTAVHFLQAEAGGGPAAAEGWRPLCAGGFTLTEVPGDHYTVLKGPGARTVATHLRALLTTPTPA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	168.35	gnl|BL_ORD_ID|4935|hsp_num:0	5928			48	1401	colistin A; colistin B
BGC0001237.1|Thiolactomycin_2 # 2795 # 9790 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=14bp;gc_cont=0.748	BGC0001237.1|Thiolactomycin_2 	2795	9790	-	Loose	500	31.187	OXA-9	34.0	3001404	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCTGAGAACGACATGGCGCGCGACGACATCGCCGTGATCGGGATGGCCTGCCGCTATCCCGGCGGTGTGGACACCCCGGAGGCGCTGTGGGACCTGGTCGCCGGCGGCCGGGACGCCGTCGGCGCGTTCCCCGACAACCGCGGCTGGGACACCGAGGATCTCTACGACCCCGCCTACGTGCGCGAGGGCGGCTTCCTGCACGGCGCCGACCGCTTCGACGCCGCCTTCTTCGGCATCCGGGCCGCCGAGGCCAAGGCCATGGACCCGCAGCAGCGCAACCTGCTCGAGGTCGCCTGGGAGGCCATCGAGCGCGCCGGCATCGTGCCCTCGACCCTCAAGGGCTCCCGTACCGGCGTGTTCGTGGGCGTCATGCCCAACGAGTACGGCATGCCGCTGTGGCGCTGGCAGGACGAGACGGCGGGCTTCATGGGCACCGGCACCTCGCCCAGCGTCGCCTCCGGCCGCATCTCCTACCTGCTGGGCCTTGAGGGCCCGGCCCTGACCATCGACACCGCCTGCTCGTCCTCCGGTGTGGCCATCCACACCGCCGTACGCTCGCTGCGCAGCGGTGAGACGGAGCTGGCGCTGGCCGGCGGCTGCACCGTACTCGCCGGCCCCGGTATGTTCGCCGACTACGCCAAGAAGCAGGCGCTGTCGCCCGACGCCCGTTGCCGCACCTTCTCCGACGCCGCCAACGGCACCGTGTGGGCCGAGGGCGCCGGCGTGCTGGTGCTCGAACCGCTCTCCAAGGCCCGTCGCCTGGGCCGCCGCATCCTCGGCGTCATCAAGGGCACCGCCGTCAACCAGGACGGCGCCAGCAACGGCCTGACCGCCCCCAGCGGCAAGGCCCAGACCAAGGTCATCGAGCAGGCGCTGGCGGACGCGGGCCTGGCCTCGCAGGACGTCCAGCTCGTCGAGGCCCACGGCACCGCCACCCGGCTGGGCGACCCCATCGAGGTCAACGCCATCCACGCCACGTACGGCGCGGGGGAGCGAGACGAGCCGGTCTGGCTCGGCTCCCTCAAGTCGAATATCGGCCACTCCATGGCCGCCGCCGGCGTGGGCGGCGTCATCAAGTGCCTCAAGGCGATGCGCGCGGGGGAGATGCCCCGCACGATGCACGTTGAGGGTCCCCTCAACTCGCTGGTCAACTGGTCCGGTTCGGTGGAGGTCCTGCGCGAGAACCGGCCCTGGCCCCTGCGTGCGGGGGTGCGGCGCTGCGCCGTGTCCTCGTTCGGCGTCAGCGGCACCAACTCGCACGTCATCCTGGAGAGCTGGCAGGAGCCGGCCGCGGATCCGGCCGACGGGGGGAGCGAGCCCGTTCCGGCCGACCGCCCCGAGGTCCTGACCCTTTCCGCCAAGACCCCGACCGCCCTGGCCGCGTACGCCGAGGCGCTGGCGAGCATGCTGGACGCCACGACGCAGCCGCTGCCGGCCGTCGCGCAGGCGCTGCGGACCCGGCGCGAGGGTTACGAGTACCGCGCGGCCGCCCTCGGCACCGACCGCGCGGAACTCGCCGCCGCGCTGCGCGCGTTCGCCGCCGGCCAGGAGGACGTCCCGGTGGTCCGCGGCGAGGCGCGCCGGATCCGCCGGCCCGTCTTCGTCTTCCCCGGCCAGGGCTCGCAGTGGCCCGGCATGGCCGCCGGGCTGCTCGCCGGGTCGGAGGTCTTCCGCCTGCGGGTCGAGGAGTGCGCCGCGGCCTTCAAGCCCCACGTCGACTACGACCTGATGGCCGTGCTCTGGGGCGAGGAAACCTCGGTCGACCTGGAGCGCACCGACGTCATCCAGCCGCTGCTGTTCTGCACGATGCTCGGCCTGACCGCCTTGTGGCAGTCGGTGGGCGTCGAGCCGGCCGCCGTGGTCGGCCACTCCCAGGGCGAGGTCGCAGCCGCCTGCCTGTCCGGGGCCCTGTCCCTGGAGGACGCGGCCCTGATCGTGGCCTGTCGCAGCCGCGTCCTCGAGGACTCCCGCGGTGGTATGGCCGCCGTGGCGGCCTCGGCCGAGGAGACGGCGACGCTGATCGCCGAGGCCGGCGCCGACCTGGTGATCGCCGCCATCAACGGCCCCTCGTTCGTGGTGGTCTCAGGCGACGACGAGCCCGGCCTCGCGCGCCTGCTCGACCTGTGCGAGGAGCGCGGCCGCTACGCCCGCCGGGTGCCCGCCAAGTGTGCCTCGCATTCGCCGGTCATGGAGGAGCTGCGCGAGGAGATCTTCGCGGGCCTCGACGGGGTCGCCCCGGTCCCGTCCACCGTCCCGATGTTCTCCACCGTCGACCGCGCACGGCTGCGTGGCGACGAGTTGGACGCCGGCTACTGGTTCCGCAACCTGCGCGGCCAGGTGCGCTTCGCCGAGACGATCGTCGAGATGGTCTCGTACGGCTTCGACGCCTTCGTCGAGATCAGCCCGCACCCCGTACTGACCGGCTCCCTCGAAGCCATCCTGCAGGAGGCCGGCAGCACCGCTCCGGTGTCCACCACCCTCAAGCGCGACCAGGGCACCCGCGAGCGGTTCCTCGCCGCGGCCGCCGAGGCGTACGTCCAGGGCCACGCGCTCGACTGGTCCCGGCTGCTGCCCGCTCCACCCGCCGCGGCCGTGGCGGCCGTGGAGCTGCCCACCTACCCGCTCGAGCGGGAGCGGTTCTGGCTGCATACCGAGGGCGTGGGCCGGATGACCCCGGCGGCCGCCCCGGCCGGCACCGCCGCCGTCCCGCGGGCGGCCGGCCCGAGCTCGGTGGCGGATGGCAGCCACCCGTTCCTGCGCTCCGTCGTCGAGACGGCCGACGGCACGGTGCTGCTCACCGGCCGGCTGTCCGTGCGCAGCCACCCGTGGCTGATGGACCACCGCGTCGAGGACACCGCCCTGCTGCCCGGTACGGCCTTCATGGAGCTGCTGCTGACCGCCGGCCGCGAGGTGGGCTGCGAGCGCCTGGAAGAGATGGTCGTCAGCGACCCGCTGCTCCTGCCGATGGGTGGCACCGCCGTGGACGTCCAGGTCGCCGTCGCGCCCGTGGACGCCCAGGGCGCGCGTGCCGCCACCGTGCACTCCCGCACCGCCGCCGACTCCGGCTGGGTGCGCAACGCGGAGGGCCTGCTGGGCGCCGCCCGCCCCGGCACCGAGACGGTCGACCTGGCGGCGGTTCCCGGCGCCTCCGCGCTGCCCTCGGCCGAGACCCTTTACCCGCGGCTGCGCGGCCTGGGCTACGGCTACGGCGAGGCCTTCCAGGGCGTGCGCTCCGGCGAGCACCTGGGCACGGAATGGGTCCGGTCCCGGGTCGAGCTGCCCGAGGCGGCCCTGGTCAACCACAGCGGTTTCGCCGCGCATCCCGCGTTGACCGACGCCGCCCTGCACGCCGCCGTAGCCTGCGGGCTGCTCGGTGAGCCGGAGCCCGGGCGGATCGCGGTGCCGTTCGTGTTCAGCGGCGTCCGGACGGCCGCTGCGGCCGGCGCCGTCGCGTGCGAGGCGCTGGCCTATCGGGTCGGCCCCGACGCGATGGCGCTGACGCTGGCCGCGGCCGACGGCACCGTACTGCTCGAAGTCGAGCGGATGGTTGTACGCGGGCTGGCCCTCGACGGGACGGGCGCCGTCCCGGTCGACCTCGACCGCGCGGGTCTGTATGAGACGAGCTGGCAGGAGCCGGCCGGCGAGGCGCCCGGGGACGTACGGCTGTGCGTGGTCGGCGGGGACGAGGGCCCGCTGCCGGCCGCGCTGCGGGACGCCAACCGGGAGGGCATCTCGGTGGCCACCCTCGACGAGGCGATCATGATCGTCTCGTCGATCCCGGGCACCTGGCAGATCGTCATGGGCTGTCCGGCGCCCAGGAACGCCACGGTCGAGCAAGTGCACGTCTCCGCCGAGCGGACCCTGGCCGCCCTGCAGACGTGGCTGCGGGCCGAGACCCTGCCGGACACGGCGGTGCTGACGTTCGTGACGCAGGACTCCGTGGCCGTCCCCGGTGACGAAACGTTTTCCCTCGGGGACAGCGCCGTCTGGGGCGTGGTCCGCTCCGCCCAGACCGAGTACCCGGGCCAGTTCCGCGTGGTCGACACCGACTCCGCGGCGTCCGGCTCCACCGAAGGCCTACTCGGCGCCCTGCGGCGCACCGAGCCGCAGCTCGCCGTCCGCGGCGGCCGCGTGCTGATGCCCCAGCTGGCCCCGCACGCCTGCGCGAGCACGCCGCGGCCCGAGGTGGGCGACGGCACCGTCGTGCTCACCGGTGGCACCGGTACTCTCGGCCGCGAGGTGGCCCGCCACCTGGTCACCGCCGGGGGCGTACGGTCCCTGGCCCTGCTCAGCCGCAGCGGAGAAGGGGCCCCCGGCATCGCGGACTTCCGCGCCGAGCTCGGTGCCCTCGGCGCCGACGTGCGGGTGTTCGCGGCCGACGTGGCCGACGCACACGACGTCCGCCGGGTCCTCGCGCAGATACGGTCTCGCGGGCCGATCGGGGGTGTCGTGCACGCCGCCGGCCTGCTCGACGACTCGATCCTCGCGAACATGACCCCGGAGCAGCTGCACCGCGTCCTGCGCAGCAAGGTCGACTCGGCCTGGCACCTGGACGCGGCGACGCGCGACGACGACCTGCGCTTCTTCGTGCTCTTCTCCTCCCTCTACGGCGTGCTCGGCGGCCCCGGCCAGGCCAACTACGCCGGTGCCAACACCTTCCTGGACCAGTTCGCCGCCTGGCGATCGGCGCAGGGACGGGCCACCCGCGCAGTGGCCTGGGGTCTGTGGGCCGAGGCCACCGGCATGACCGGACATCTCGACGAGAGCGACCTGCTGCGCCTGCGGCGCAACGGCATCGCGCCCTTCGAGACGGCCGCCGGCCTGGCCCTCTTCGACGCCGCCGTGGCCGGCATCGCGCCTGCCCTCGTCGGCGCCCGGCTGGCCCTGCCGGACGAGACCGGGCCCGGGGCGGGCGACGTCCCGTTCCTGCTGAACCAGCTGGCGGGCGCGGCGGGCGGCACCGGCAGCGGGCCCGTCGTCCGCGCCGCCGTCCCGCTGCCCGCGGAGGCCGGGGTCCGGACCGCCGCGCCGGGAGCTACGGCCGCTCCCGGACGTACGGCCACTCTCGGAGCGGCGGGCGCTCCGGTACGTACCGCCGCCCCGCTGCGGGGGACCGGCCCGGCCACCCCGGCCGTGGCCGCCGCCGCTCGCGCCGTCGCCGGCACGGCGGACGCCGCCGAGCAGCCCGGCGCCGCCGCGGTCGCGGTGCTGACCTCCCGCGACGCCTCGGCCGACCAGCGGCTGGTCGCCGCGGTCGGGCTGGTCAAGGAGTGCGTGGCCGGCCTGCTGGGCCTCAAGGCCGAACGGGTGGACGCGCAGCGCTCGTTCTACGAGATGGGCGTCGATTCCCTGACCTCCATGGAGCTGCGGGTCCGGCTCGGCAAGATCCTGGGCATCCGGCTCGGGGCCACCGCGGTCTTCGACCACCCGACGCCGGAGGCGCTGGCCCAGCACGTCGTCGACCTGTTCGGCCCGCCCGGACCGTCCGGCGGCGGTGGCGGCACGGGCCCGCAGCGGACCCCGGGCGGCCCGGGAAATGATGGTGCGTCCGCGGCGGAGGCCGCCGCGGACGCGCACTCCGGGACCCGGGCCGCCGGCCCGCAGGACCGTACCGGCTCCGTGGGCGCCGAGCCCGCCGACCCGGCCGGCGCACCGCGGCGGCCGGCCCGGCCGGACTCGCCGCCGTTCCCGCTCACCAAGCTGCAGGAGGCCTACCTCGCGGGCCGTGGCGGGGACTTCGAGCTGGGCGACGTACCCACGGTCCTGTGCATCGAGGTCGACCTCACCGGGTTCGACGTACGGGCCGCCGAGCGGGCCTTCCGGCAGCTCGTGGACCGCCACGAGATGCTCCGGGCGGTCTTCGACGTCGCCGGCGCCCAGCGGGTGCTCGGCGAGGTGCCGGACTTCCGGATCCCCGTCGAGGACATCCGCGCGCTCGGCCCCGACGAGCGGGCCGCCCGGCTGGCCGCCATCCACGAGGAGGTGACCACGCACACCTTCGACACCACCCGCTGGCCGCTGGTCCTGGTCTGGGCCACCCGCGTGGACGAGTCGGTCACCCGGCTGCACGTGGCCGTCGATGTCCTGGTGTCGGACGGCGCGAGCAGCACGCTCCTCTTCAACGAGTGGGCCCGCCTCTACCGCGACCCGCAGGCTCCGCTGCCCGCGACCGGCCCCTCGTTCGCCCATCACGTGGCGCGGGCCGCCGCGTACCAGGCCTCCCCGGAGATCGAGCCCAGCCGCGCCTACTGGCAGCAGCGCGCGGCGAGCCTGCCACCCGCGCCGCTCCTGCCGTACGCCGTGCCGCTGTGCGACGTCGGCCGGCCGGCCTTCGGCAACCGGTTCATTCGGGTCGAGGCGCCGCAGTGGCAGCGCTTCAAGAAGAACGCGGCGGCCGCCGGCCTGACCGCCTCCGGCGCCGTCCTCGCCGCGTACTGCCACGTGCTGGCCCGCTGGTCCAAGGTCCCGGACTTCACCCTCACGGTCCTGGTCTCCCAGCGCTCCACCTTCGCCGAGGAGGACCTGTCCACGGTCGTCGGTAACTTCTCCTCCACCATGCTGCTGGAGGTCCACGTCGACGAGGCGGCCCCGTTCCGCGAGGTCGCCGCGGGCATCCAGCGCCGGCTGCTGCAGGACATGGAGCACGTCGCCTACACCGGCCTCGACGTCCTGCGTGACCTGAGCCGGCTGGACGGGCAGGCCGGCCAGGCCCGGTTGCCCGTCGTGTTCAACAGCACCATCGGCGCCGTCGCGTCCGCACCCGGCGCCCCGCGCACGGCCGGCCCGGTGGGCGCCCTGTGCCTCCTCGGCGACTCGGGCACCCCGGTATGGAGCGGGGTCCGCACGCCCCAGGTCGTCCTGGACCACCAGGCGTTCGAGGAGGACGGAGCGCTCGTCCTCAACTGGGACGTGGTCGAAGAGGTGTTTCCCGAGGGCGTCGTGGACGCCATGCTCGCCGCTTACGAAGGACTGATCCGTGAACTCTGTGCCTGA	MAENDMARDDIAVIGMACRYPGGVDTPEALWDLVAGGRDAVGAFPDNRGWDTEDLYDPAYVREGGFLHGADRFDAAFFGIRAAEAKAMDPQQRNLLEVAWEAIERAGIVPSTLKGSRTGVFVGVMPNEYGMPLWRWQDETAGFMGTGTSPSVASGRISYLLGLEGPALTIDTACSSSGVAIHTAVRSLRSGETELALAGGCTVLAGPGMFADYAKKQALSPDARCRTFSDAANGTVWAEGAGVLVLEPLSKARRLGRRILGVIKGTAVNQDGASNGLTAPSGKAQTKVIEQALADAGLASQDVQLVEAHGTATRLGDPIEVNAIHATYGAGERDEPVWLGSLKSNIGHSMAAAGVGGVIKCLKAMRAGEMPRTMHVEGPLNSLVNWSGSVEVLRENRPWPLRAGVRRCAVSSFGVSGTNSHVILESWQEPAADPADGGSEPVPADRPEVLTLSAKTPTALAAYAEALASMLDATTQPLPAVAQALRTRREGYEYRAAALGTDRAELAAALRAFAAGQEDVPVVRGEARRIRRPVFVFPGQGSQWPGMAAGLLAGSEVFRLRVEECAAAFKPHVDYDLMAVLWGEETSVDLERTDVIQPLLFCTMLGLTALWQSVGVEPAAVVGHSQGEVAAACLSGALSLEDAALIVACRSRVLEDSRGGMAAVAASAEETATLIAEAGADLVIAAINGPSFVVVSGDDEPGLARLLDLCEERGRYARRVPAKCASHSPVMEELREEIFAGLDGVAPVPSTVPMFSTVDRARLRGDELDAGYWFRNLRGQVRFAETIVEMVSYGFDAFVEISPHPVLTGSLEAILQEAGSTAPVSTTLKRDQGTRERFLAAAAEAYVQGHALDWSRLLPAPPAAAVAAVELPTYPLERERFWLHTEGVGRMTPAAAPAGTAAVPRAAGPSSVADGSHPFLRSVVETADGTVLLTGRLSVRSHPWLMDHRVEDTALLPGTAFMELLLTAGREVGCERLEEMVVSDPLLLPMGGTAVDVQVAVAPVDAQGARAATVHSRTAADSGWVRNAEGLLGAARPGTETVDLAAVPGASALPSAETLYPRLRGLGYGYGEAFQGVRSGEHLGTEWVRSRVELPEAALVNHSGFAAHPALTDAALHAAVACGLLGEPEPGRIAVPFVFSGVRTAAAAGAVACEALAYRVGPDAMALTLAAADGTVLLEVERMVVRGLALDGTGAVPVDLDRAGLYETSWQEPAGEAPGDVRLCVVGGDEGPLPAALRDANREGISVATLDEAIMIVSSIPGTWQIVMGCPAPRNATVEQVHVSAERTLAALQTWLRAETLPDTAVLTFVTQDSVAVPGDETFSLGDSAVWGVVRSAQTEYPGQFRVVDTDSAASGSTEGLLGALRRTEPQLAVRGGRVLMPQLAPHACASTPRPEVGDGTVVLTGGTGTLGREVARHLVTAGGVRSLALLSRSGEGAPGIADFRAELGALGADVRVFAADVADAHDVRRVLAQIRSRGPIGGVVHAAGLLDDSILANMTPEQLHRVLRSKVDSAWHLDAATRDDDLRFFVLFSSLYGVLGGPGQANYAGANTFLDQFAAWRSAQGRATRAVAWGLWAEATGMTGHLDESDLLRLRRNGIAPFETAAGLALFDAAVAGIAPALVGARLALPDETGPGAGDVPFLLNQLAGAAGGTGSGPVVRAAVPLPAEAGVRTAAPGATAAPGRTATLGAAGAPVRTAAPLRGTGPATPAVAAAARAVAGTADAAEQPGAAAVAVLTSRDASADQRLVAAVGLVKECVAGLLGLKAERVDAQRSFYEMGVDSLTSMELRVRLGKILGIRLGATAVFDHPTPEALAQHVVDLFGPPGPSGGGGGTGPQRTPGGPGNDGASAAEAAADAHSGTRAAGPQDRTGSVGAEPADPAGAPRRPARPDSPPFPLTKLQEAYLAGRGGDFELGDVPTVLCIEVDLTGFDVRAAERAFRQLVDRHEMLRAVFDVAGAQRVLGEVPDFRIPVEDIRALGPDERAARLAAIHEEVTTHTFDTTRWPLVLVWATRVDESVTRLHVAVDVLVSDGASSTLLFNEWARLYRDPQAPLPATGPSFAHHVARAAAYQASPEIEPSRAYWQQRAASLPPAPLLPYAVPLCDVGRPAFGNRFIRVEAPQWQRFKKNAAAAGLTASGAVLAAYCHVLARWSKVPDFTLTVLVSQRSTFAEEDLSTVVGNFSSTMLLEVHVDEAAPFREVAAGIQRRLLQDMEHVAYTGLDVLRDLSRLDGQAGQARLPVVFNSTIGAVASAPGAPRTAGPVGALCLLGDSGTPVWSGVRTPQVVLDHQAFEEDGALVLNWDVVEEVFPEGVVDAMLAAYEGLIRELCA	MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVVWFSQQLTSRLGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKEQIQFLLRFVAHKLPVSEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQGWFVGWAEKNGRQVVFARLEIGKEKSDIPGGSKAREDILVELPVLMGNK	850.73	gnl|BL_ORD_ID|219|hsp_num:0	243			531	672	cloxacillin; oxacillin; cefalotin
BGC0001237.1|Thiolactomycin_3 # 9783 # 12002 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.763	BGC0001237.1|Thiolactomycin_3 	9783	12002	-	Loose	750	80.1073	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.12	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACACAGCACACTTCCGGCGGCGGGGCCATGACCCCCGTCGCCGTCATCGGGATGTCCTGCCGGTTCCCGGGAGCGGCCGGTCCGGCCCGCTTCTGGCGGAACCTGGCCGCCGGCACGGAGAGCGTGGGCCCCGTCCCCGCGGACCGCCGGCCGGCCGGCGGCACCGCTGTCGCCGCGCGCGGCGGCTTCGTCGAGGCGGTCGACGCCTTCGACGCCGCGTTCTTCGGCGCCTCCCAGCGCGAGGCGCAGTACATGGACCCCCAGCAGCGGCTGCTGCTGGAGCTGGCCTGGGAGTGCCTGGAGGACGCCGGACGGCCGGCCGCAGACCTGCGCGACTGCGGCTGGGGGGTGTTCGTCGGCGCTGCCGCCGACGACTTCCGGGCGGACTACCTGACCGGGGGCGCACTGGACCGGTTCGGCCACACCGGCACCGCCCGGTGCATGCTGGCCAACCGGATCTCCCACCACTTCGGGCTGCGCGGCCCGAGCGAGGTGGTGGACACCGGTCAGTCCTCCTCCCTGACCGCCCTGCACCGCGCGGTGTCGAGCCTGTGGCTGGGCGAGTGCGAGGCCGCGCTCGTCGGCGGCGTACAGCTCAACCTCCTTCACGAGGTCACCGAGCAGATCGGGCTGTGGGGAGGGCTGTCCCCGGACGGCCGCTGCCACACCTTCGACGGCCGCGCCAACGGCTACGTCCGCGGCGAGGGCGGCGGCTGCGTCCTCCTCAAGCCGCTGCCGGCCGCCCTGCGCGACGGCGACCACGTCTACGCCGTCGTCCGTGGCAGCGCCGTCGCCAACGACGGCGGCCGCGGCGGCTTGGCCGTACCGTCCCGGGAGGCGCAGTACGAGGCTGTCACCCGCGCCCTGCGGGTGGCGGGGGCCCGGCCGGAGGACCTCGCGTACGTCGAACTCCACGGCACTGGAACCCCGGTGGGGGACCCGGTCGAGGCCCGCGCGCTCGGCGCGGCCGCCGGCCGCGCCCGGCCCGCCGGGAACCCGCTGCCGGTCGGGTCGGTCAAGACCAACATCGGCCACCTGGAGTCCGCCGCCGGCATCGCCGGGTTTATCAAGGCCTGCCTGGTGCTGGAGCACGGGGCCCTGCCGGCGAGCCTGAACTTCGAGGCCCCCGGCCCCGCCCTCGACCCGGCCGGCCTCGGCCTGCGCGTCGTCAACGCCTACGAGGAACGGGACTTCGGCGCCGACGAGCTGGTCGGCGTCAGCTCGTTCGGGATGGGCGGCACGAACGTCCACGTCGTGCTGGGCGCGGCCCCGGCCCCGGCCGCGGACCCGGTGCCCGACCCCGACGAGGACGCCGACAGCGGTGCCGTGTGGTGCCTGTCCGGACGCTCCCAGGAGGCGGTCCGCGACCTCGCGTACGCCCTGCTCGCAGAGCTCGACCGGCATCCGGCCGGCGGTCCCGAGGCCGGCTTCCGCGCGGTCGCGGCCACCCTGGCCCGCCGCACCCACTGGGAGCACCGGGCCGCGGTGGTGGGCGCCGACTGGACGCACTTCCGCGAGGGCCTGGCGAAGGTGGCCGCCGGCCACGGATTCGCCGTGCCCTCGGACTGGGCGACGGCGGGCGGCCCGGACGGGGCCGGCCCCGTCCGGGCCGCCGGCGACTACGTCCACGCGGGCCGGGTCCCCGAGATATCGGCCCCCTCCGCGCAGCGGAAACTGCCCCGGCCGGTGCCGGGCCTGCCCACGTACCCCTTCCAGCGGGACCGCTTCCCGCTGCCTGCCCGGGCCGCCTCCCACGCGGCCCCCGGCACCGGTGCGGCCACCCCGGCTACCGCGCCTGCCGCGCCTGCCGCGCCTGCCGCGCCTGCCGCAACTACCGCGCCTGCCGCAACTGCCGCGCCTGCCGCAACTGCCGCGGCGTCCGCGGCCGTCCCGGGCCCTGCTTCCGACGCCGGGCACGCCGGCACGGCGTACGCGCGGTCCTGGGCGGCCGCCAGCGACGCGGGTGACCGGCTCTGGGCCACCCAGGTCCTCCTCGAACGCGAACTCGCGGCCGTGCTCGGCGGATCCGTCCCCGACCTGGACCCCGAGGTCTCCCTCACGGACCTGGGCGTGGACTCCATGACCCTCCTGGAGTTCCTGGACCGGCTCATCGAGGCGACCGGCCTCACCCTCTCGGAGACCGTCGTCTTCGACCACCCCACGATCAGCGAAATGGCGGCACGTGTGAACCAGGAGATGGGGTCCAGGCATGGCTGA	MTQHTSGGGAMTPVAVIGMSCRFPGAAGPARFWRNLAAGTESVGPVPADRRPAGGTAVAARGGFVEAVDAFDAAFFGASQREAQYMDPQQRLLLELAWECLEDAGRPAADLRDCGWGVFVGAAADDFRADYLTGGALDRFGHTGTARCMLANRISHHFGLRGPSEVVDTGQSSSLTALHRAVSSLWLGECEAALVGGVQLNLLHEVTEQIGLWGGLSPDGRCHTFDGRANGYVRGEGGGCVLLKPLPAALRDGDHVYAVVRGSAVANDGGRGGLAVPSREAQYEAVTRALRVAGARPEDLAYVELHGTGTPVGDPVEARALGAAAGRARPAGNPLPVGSVKTNIGHLESAAGIAGFIKACLVLEHGALPASLNFEAPGPALDPAGLGLRVVNAYEERDFGADELVGVSSFGMGGTNVHVVLGAAPAPAADPVPDPDEDADSGAVWCLSGRSQEAVRDLAYALLAELDRHPAGGPEAGFRAVAATLARRTHWEHRAAVVGADWTHFREGLAKVAAGHGFAVPSDWATAGGPDGAGPVRAAGDYVHAGRVPEISAPSAQRKLPRPVPGLPTYPFQRDRFPLPARAASHAAPGTGAATPATAPAAPAAPAAPAATTAPAATAAPAATAAASAAVPGPASDAGHAGTAYARSWAAASDAGDRLWATQVLLERELAAVLGGSVPDLDPEVSLTDLGVDSMTLLEFLDRLIEATGLTLSETVVFDHPTISEMAARVNQEMGSRHG	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	177.64	gnl|BL_ORD_ID|1968|hsp_num:0	1943			513	1242	isoniazid
BGC0001237.1|Thiolactomycin_5 # 13298 # 14290 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.747	BGC0001237.1|Thiolactomycin_5 	13298	14290	-	Loose	750	297.745	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	49.55	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGGCCCTGGTCACCGCCCGCGAGGCGTGGGCCGACGCGGGCAGCCCACGGCCCGACCCCGAGCGCCTCGCCGTGGTCATCGGCACCGGCATCGGCGGCGTGACCTCGCTGCTGGTCCAGAACCACGTCCTGGAGACTTCCGGCCCGCGCCGGGTCTCGCCGCACGCCGTCCCCATGCTGATGGCCAACGGCCCTGCCGCCTGGGTCAGCATGGACCTGGGCGCCCAGGCCGGTGCGCACGCCCCGGTCAGCGCCTGTGCCTCCGGCGCCGAGGCCATCGCCCTCGGCCTGGACCTCATCCGCTCGGGCCGTGCGGACATCGTTGTCGCCGGTGGTGTGGAGGCCAGCGTCCACCCGCTGCCGCTGACCGCGTTCGCGCAGATGATGGCGCTGTCCACGCAGAACGACGACCCGGCGCACGCCTGCCGTCCCTTCGACACCAAGCGGGGTGGCTTCGTCCTCGGCGAGGGCGCCGCCCTGGTCGTCCTGGAGCGGGCCGACCACGCCCGGGCCCGCGGCATCGCCTCCCCGCACGGCACCGTCCTCGGCGCCGGCATCAGCTCCAGCGCCACCCACATCACCGCCTCCGACGTCGCCGGGCAGGTCCGCGCCATGCGGATGTCGCTGCGCGACGCCGACGTCGCCGCCGAGCGGATCGGTCACGTGCACGCGCACGCCACCTCCACCCCGCAGGGCGACGTGGCGGAGGCCCGCGCCATCGCCGAGGCCATCGGCACCCACCCCGTGGTGAACGCGACGAAGTCCATGACCGGGCACCTGCTCGGTGCCTCCGGCGCGCTCGGCGCCATCGCCGCGCTGCTAGCGCTGCGCGACGGCCGCGTACCGCCCGTGCGGAACCTGGAGGAGCTCGACCCCGACGTCGAACTGGACGTCGTCCGCGGCGCCCCGCGCACCGGGAGCTGGGAGTGCGCGCTGGCCAATTCCTTTGGCTTTGGCGGGCACAACGTCTCCCTTGTCCTCGGCCGGCCGTAA	MALVTAREAWADAGSPRPDPERLAVVIGTGIGGVTSLLVQNHVLETSGPRRVSPHAVPMLMANGPAAWVSMDLGAQAGAHAPVSACASGAEAIALGLDLIRSGRADIVVAGGVEASVHPLPLTAFAQMMALSTQNDDPAHACRPFDTKRGGFVLGEGAALVVLERADHARARGIASPHGTVLGAGISSSATHITASDVAGQVRAMRMSLRDADVAAERIGHVHAHATSTPQGDVAEARAIAEAIGTHPVVNATKSMTGHLLGASGALGAIAALLALRDGRVPPVRNLEELDPDVELDVVRGAPRTGSWECALANSFGFGGHNVSLVLGRP	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	79.33	gnl|BL_ORD_ID|1968|hsp_num:0	1943			255	1245	isoniazid
BGC0001237.1|Thiolactomycin_7 # 14873 # 17434 # 1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.754	BGC0001237.1|Thiolactomycin_7 	14873	17434	+	Loose	400	32.3426	salB	24.05	3007026	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	TTGAGGGGAGCGTCTGTGGGGACGGCAGACGGGCATCGGGCGCGCGAGGTCCTGGAAGACCTGTTCGCGCGGGCAAGGGAGGGCCAGGGACGGGCGGTGCTCGTCACCGGGGCGGCGGGCATGGGCAAGACCACCCTCGTCCACGAGCTCCAGAACCACGCGCTGAGCTCGGGTGCCAGAGTGCTCACCGCCATCGCCTCGCGCGCCGAGCGCGACCTCCCGATGGGCGTCGTCGGCCAGCTGGCGGCGGCCGCCCACCCCGCTAGCCCGGCCGCGGCCGGCGCGGACCCGGGTACGGGCGCGACGCTCCAGGCCGTCGACGCCTTCCACCGCCTCATGCTCGGGCTGGCCGAACGTGACCCCCTCGTCATCACCGTGGACGACGCGCACGAGATGGACGCCGCCTCCCGGCACTGCCTGCTGTACCTGGTCCGCCGGGTGGGCGCCTCCCGGATCCTGCTGGTGCTCGGCGAGCGGGCCGACACCTCCCAGCCGGGCTCCACGCTCACCTCGGAGTTCGTCCGCAATCCGCACTGCGCGCTGGTTCAGCTGGGCCGGCTTTCCGTCGCCGGCACCGAGTCCGTGCTCGCCGCGCTTCCCGGCGCCCGGCCGGCCGCGGAGAGCGCGCCGCTCTGGCAACGCGCCTCGGGCGGCAGTCCGCTGCTGCTGCAGGCACTGCTCGACGACCGCGCCGACGGCGCGGCGGCGGAGCCGGCCGCCGGTCAGGCGTTCGCGCTGGCGGTGCGCCACCTGCTCGACCAGCTCGACCCGGCCACCGCCCGCACCGCCCATGGCCTGGCCGTCCTGGGCGACGACGCTACGGCCGCGGACCTCGACCGGCTGCTGGACCTGCCCGCCGGTACGGCCGCCCGGGCCATGGCGACCACGGACGCACTCGGCCTGACCGAGGAAGGCCGTTACCGCGTCGCGGCCGCGCGCGCCACCGCGCTGGCGGAGCTGCGCCCCGAGGAGCGGGCCGCCCTGCACCGGGCCGCGGCCCGGCTGCTCTATCAGCACCGGGCCGCGACCAGCGAGGTGGCCCGCCACCTGGTCGTCGGCGGTCCGGTCGACGAGAGCTGGGGGCTGGCCGTACTGCGTGACACGGCCCAGCAGGCCCTGCGCACGAACGACCCGGTACGCGCCCTGACCTGCCTGCGGGTGGCGCACGACGCGTGCCCCGACCCGCGCGAGCAGGCTCAGGTGCGCGCCGAACTGGTGCAGGCCGAATGGGAGGTGGACCCCGCCGCCGTCCGCGTCCACCTGCCCTGTCTCGTCAAGGACCACCGCGCCGGGCTGCTCGAACACCGGCAGAGCATCCGCCTGATCGCCCACCTGCTGTGGCACGGCCGGCCTGAGGAGGCGGACGCCCTGTTCGCCGACCTGGACCCGGTGGAGGGCCGGCTGCCGGGGGACTGCCGGGCGCAGTTGGAGACGATGCGGGTCTGGTTCGCGCACTCGTACCCGGTGCTCGGAGCCCGTTACCGGGCGCACACGCTGCTGGACGAGGCGGCGCTCAGCCGGAGCGTGGGCGCCGTGGATCCGCAGGCCGACGGGGCTCTGCTGCTGCACGCGCTGATGTCCGAGGGGCCGACCGGGAAGGTGCTGGAGACCGCCGAACGGCTGCTCCAAGGCATGGTGCTGCACGATCCGCCGGTGGCCCCGACCATCGCCGCGCTGGCCACGTACATGCACGCCGCCCGGCTGGACCGGGCCGCGGACTGGTGCGACCTGCTGCTGCGGGAGGCCGACCGGCGCACGCCGGTGATCCGGGCGATTCTCGCCGCCGCCAGTGCCGCGGTCGAGAGCCGGCTCGGCAACTTCGAGGTGGCCCGCCAGCGGGCCGACCTTGCGCTGACGCTGGTGGGCCCGACCGCCTGGGGCATCGCCCTCGGCGTGCCATTGGCCGCCAAGGTGCTGGCCTGCACGGCCCAGGGCGACCGGGAGGGGGCCGCCGAGTGCTTCCGGGTGCCGGTGCTCGACGTGATGTTTCAGACCCTACCCGGATTGCACTACCTGCAGGCGCGGGGCCGCTACCACCTCTCGGTGGGCCGCTACCACGCGGCGCTCGGCGACTTCCACGCCTGCCGCGACCTGATGGCGGCGTGGAACCTGGACGTCTCGGCGTCCCTGTCGTGGCGGGCGTACGCCGCCGAGGCACTGATCGAGCTCGACAGCCCGGCGCAGGCCCGGGAGCTGCTGGCGGAGGAGCTGGCCCAGCAGGGCGACGGCAGCGGCGGCAACCCGTGGCTGAAGGAACGTTCGCTGCAGCTGCTCGACCGGCTGGGCAGCCCCCGGCCGGCCGGGTCCGCCGCGACCGCCCCAGGCCGGGGCGGGCCGGAGGAGAGCGGTCCCGAGGAGCTGAGCAAGGCGGAGCAGCGGGTGGCGCTGCTGGCCTCGCAGGGTTGCACGAACCGGGAGATCGCGGCCCGGCTGTTCGTCACGGGGAGCACCGTCGAGCAGCACCTGACCCGCGCCTACCACAAGTTGGGGGTGCGGGGCCGGGCCGATCTGCCCGCGGTGCTGGGCCGGGTGCCGGCCGGCAGAAGGGGCTCCGACTCTTAG	MRGASVGTADGHRAREVLEDLFARAREGQGRAVLVTGAAGMGKTTLVHELQNHALSSGARVLTAIASRAERDLPMGVVGQLAAAAHPASPAAAGADPGTGATLQAVDAFHRLMLGLAERDPLVITVDDAHEMDAASRHCLLYLVRRVGASRILLVLGERADTSQPGSTLTSEFVRNPHCALVQLGRLSVAGTESVLAALPGARPAAESAPLWQRASGGSPLLLQALLDDRADGAAAEPAAGQAFALAVRHLLDQLDPATARTAHGLAVLGDDATAADLDRLLDLPAGTAARAMATTDALGLTEEGRYRVAAARATALAELRPEERAALHRAAARLLYQHRAATSEVARHLVVGGPVDESWGLAVLRDTAQQALRTNDPVRALTCLRVAHDACPDPREQAQVRAELVQAEWEVDPAAVRVHLPCLVKDHRAGLLEHRQSIRLIAHLLWHGRPEEADALFADLDPVEGRLPGDCRAQLETMRVWFAHSYPVLGARYRAHTLLDEAALSRSVGAVDPQADGALLLHALMSEGPTGKVLETAERLLQGMVLHDPPVAPTIAALATYMHAARLDRAADWCDLLLREADRRTPVIRAILAAASAAVESRLGNFEVARQRADLALTLVGPTAWGIALGVPLAAKVLACTAQGDREGAAECFRVPVLDVMFQTLPGLHYLQARGRYHLSVGRYHAALGDFHACRDLMAAWNLDVSASLSWRAYAAEALIELDSPAQARELLAEELAQQGDGSGGNPWLKERSLQLLDRLGSPRPAGSAATAPGRGGPEESGPEELSKAEQRVALLASQGCTNREIAARLFVTGSTVEQHLTRAYHKLGVRGRADLPAVLGRVPAGRRGSDS	MLFLFEEKPLEIENKQLIKRLSFHIEDHEHLALIGVNGIGKSTLLHHIHKNELIDTAMMEQDLSKHDDIDVMDYVMSAYPKLVELRKDLSDIDSLNSYIELDGYNVENNIIIEGNKLGLSSTHFEQKIGTLSGGEQTKVSFLKVILSDAPLLLIDEPTNHMDKEMKVWLIKAFKSEQRAILFVSHDREFLNETPDAILELTKDGATRYSGHYDDYKNQKDIEIETEKLKYEKEQKEQKAIEESIKKYKEWYQRAAQKASVRSPYAQKQLSKLAKRFKSKEHQLNRKLEESKSDNPLEENKSFSIENNEFKSHYLVRFENVSFSYKSREIFKDTYFEIKRNQTVIIEGKNGSGKSTLIQLILGNLLPMSGAVKKHPDLDIGYFSQDFQNLNPNNSVLEEVMDIENMMITDARTILASFYFDKSRMNDKVRQLSMGEKCRLQFVKLYFSNPHILILDEPTNYFDISMQEKIIQLIQSFNGAVIIVSHDEIFKDEIRDQVWKIENCKLIHENVSINTPIDAESMKDELKILEQYTDERNKETDF	157.67	gnl|BL_ORD_ID|4725|hsp_num:0	5737			966	1179	lincomycin; clindamycin; virginiamycin M1; tiamulin; retapamulin
BGC0001237.1|Thiolactomycin_8 # 17447 # 17749 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.756	BGC0001237.1|Thiolactomycin_8 	17447	17749	+	Loose	525	25.7942	DHT2-1	34.43	3006872	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	DHT2 beta-lactamase	GTGGCGCGCCCGACGGAAGCCCTGGCCGCCCTTGCGGCCGAGGCAGCCGCGGGCCGCCAGCTGTTCCAGCAGCGGCGGGGTGTAGCCGCCTTCGGGGAACTCCCCGTCCAGGCGCCGCAGGGCGGCCCGGGAGACGTCGAGCCCGATGGTGTCGAGCAGGGCGAACGGCCCCATCGGGTGGCCCAGGCCCTGTTCGAAGGCGGCGTCGATCCGCTCGATGTCGACGTCGTGACCGTCCCGTCCGTCGAGCAGGCCGAGGGCGGCGCGCTTGTCCTGCGGGCCGAAGCCGGACCGCGCGGTTGA	MARPTEALAALAAEAAAGRQLFQQRRGVAAFGELPVQAPQGGPGDVEPDGVEQGERPHRVAQALFEGGVDPLDVDVVTVPSVEQAEGGALVLRAEAGPRG	MSSIVRGVRAAVVASAISLAAAFACLPLAAADATREPVLPQSGRYEVPDSWRQPIAPVRIADHTWYIGTENLSAVLVTTPQGAVLIDGGMPQAADMLLQRMRDVGIAPGDLRWILVSHAHADHAGPVAKVKRATGARIAANAESAAMLARGGTDDIHFGDDITFPPAQADRLLQDDEVVQVGGIALTGHVTPGHTPGSTSWTWTDTKDGKPVRIAYADSLSAPGYKLIGNPRMPRIVEMYEATFAKVRALPCDLLLTPHPDASGWTPADAANPHPSPKTCAAYADEMEAKFDAELAKQRAAK	33.11	gnl|BL_ORD_ID|3515|hsp_num:0	4584			60	240	
BGC0001237.1|Thiolactomycin_9 # 17796 # 18314 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.742	BGC0001237.1|Thiolactomycin_9 	17796	18314	-	Loose	400	26.5646	AAC(3)-IVa	38.46	3002539	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCCGCTCAACTCATCCGTCGTCGGCGTCGTCGGGCTCGGCTCCGTCGGCCTGCCCCTGCTCGCCCTGCTGCACACCGCCGGTCACGAGGTCATCGGTGTCGACCAGGAAGCCGACGTACTGGCCCGCGCGGAGCGGTGGATGAAGGCCCGAGCGGCCGTCGGTGAGGGTCCGGCCGGTGGCTACACGCTCACGAACGACACGGTCGCCCTGGTCGGGGCCGACGTGGTCGTCGAGGCCGTGCCGGAGGACCTGGCCGGCAAGACCGAGGTCCTTCGCCGGCTGCACGCCGTCTGCCTGGACGGCGCCGTCCTGGTGAGCACCTCGGCCTCGCTGTCGTTGCCGCAGCTGGCGATCGCGTCCGGCCGGCCGGCCCGCACGCTGGGGCTGCGCATGCTGCGGCCGCCGGCCCCCGGCGGCACCGTCGAGTTGCTGTGCACCGCCATGAGTAGCGACGACGCCGTCGCCGCGCTGGAGGCCCTGCTCGACGGGATCGGCCTGGCGGCGGCCGCCCCGTAA	MPLNSSVVGVVGLGSVGLPLLALLHTAGHEVIGVDQEADVLARAERWMKARAAVGEGPAGGYTLTNDTVALVGADVVVEAVPEDLAGKTEVLRRLHAVCLDGAVLVSTSASLSLPQLAIASGRPARTLGLRMLRPPAPGGTVELLCTAMSSDDAVAALEALLDGIGLAAAAP	MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVMPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLPLPPHSPASPVARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVRVDYLENDHCCERFALADRWLKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFLHPPEAGCEECDAARQSIG	66.67	gnl|BL_ORD_ID|4915|hsp_num:0	639			558	636	dibekacin; sisomicin; apramycin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0001237.1|Thiolactomycin_10 # 18357 # 19700 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0001237.1|Thiolactomycin_10 	18357	19700	-	Loose	660	55.8398	MexS	29.31	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAAGAAATAGTCAGCGCCATCCTTTCCGACGACGTCGCGGCCGGCGATATCGCCGCTCTGTCGATCCCCGAGAGCTACCGGGGGAGCGTCGTAAGAAAAGAAGACGTCGGCATGTTCGAGGGCCTGGCGACGGCGGACAAGGACCCGCGCAAGTCCTTGCACGTGCAGGACGTCCCGACACCGGAGCCGGGTCCGGGCGAGGCCCTGGTGGCCGTCATGGCCTCCTCGGTCAACTACAACACCGTCTGGTCTTCGATCTTCGAGCCGCTGCCGACGTTCGGATTCCTGGAGCGCTACGGCCGACTCAGCGAACTCACCAAGCGCCACGACCTGCCGTACCACGTCCTCGGCTCCGACCTTGCGGGCGTCGTCCTGCGCACCGGACCGGGCGTCAACCGCTGGAAAGCCGGCGACCGCGTCGTGGCCCACTGCCTGTCGGTGGAGCTGGAGTCCGCCGACGGCCACGACGACACGATGCTCGACCCCGAGCAGCGGATCTGGGGCTTCGAGACGAACTTCGGCGGTCTCGCGGAGATCGCGCTGGTCAAGTCCAACCAGCTGATGCCCAAGCCGGCCCACCTCAGCTGGGAGGAGGCCGCCTCCCCCGGCCTGGTGAACTCCACCGCCTACCGCCAGCTGGTCTCGCGCAACGGCGCCGGCATGAAGCAAGGCGACAACGTTCTGATCTGGGGCGCCAGCGGCGGCCTGGGCTCCTACGCCACCCAGTTCGCCCTGGCCGGCGGCGCCACCCCCATCTGCGTGGTCTCCTCCCCCGAAAAGGCCGAGATCTGCCGCAAGATAGGCGCCGATGCGGTCATCGACCGCAACGCCGAGGGCTACAGGTTCTGGAAGGACGAGCAGACCCAGGACCCGCGCGAGTGGAAGCGCTTCGGCTCCAAGATCCGCGAGCTGACCGGCGGCGAGGACATCGACATCGTCTTCGAGCACCCGGGCCGCGAGACGTTCGGCGCCTCGGTCTACGTCACCCGCAAGGGCGGCACGATCACCACCTGCGCCTCCACCTCCGGCTACATGCACCAGTACGACAACCGGTACCTGTGGATGTCGCTCAAGCGCATCATCGGCTCCCACTTCGCCAACTACCGCGAGGCCTGGGAGGCCAACCGCCTCGTCGCCAAGGGCAAGATTCACCCCACCCTCTCCAAGACCTACTCCCTGGAGGAGACGGGCCAGGCGGCGTACGACGTCCACCGCAACCTCCACCAGGGCAAGGTCGGCGTGCTGTGCCTCTCGCCCGAGGAGGGCCTGGGCGTGCGCGACCACGACATGCGCGCCGAACACCTCGACGCCATCAACCGCTTCCGGGCCACCGGCCGCTGA	VKEIVSAILSDDVAAGDIAALSIPESYRGSVVRKEDVGMFEGLATADKDPRKSLHVQDVPTPEPGPGEALVAVMASSVNYNTVWSSIFEPLPTFGFLERYGRLSELTKRHDLPYHVLGSDLAGVVLRTGPGVNRWKAGDRVVAHCLSVELESADGHDDTMLDPEQRIWGFETNFGGLAEIALVKSNQLMPKPAHLSWEEAASPGLVNSTAYRQLVSRNGAGMKQGDNVLIWGASGGLGSYATQFALAGGATPICVVSSPEKAEICRKIGADAVIDRNAEGYRFWKDEQTQDPREWKRFGSKIRELTGGEDIDIVFEHPGRETFGASVYVTRKGGTITTCASTSGYMHQYDNRYLWMSLKRIIGSHFANYREAWEANRLVAKGKIHPTLSKTYSLEETGQAAYDVHRNLHQGKVGVLCLSPEEGLGVRDHDMRAEHLDAINRFRATGR	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	131.86	gnl|BL_ORD_ID|1039|hsp_num:0	1041			33	585	ciprofloxacin; trimethoprim; chloramphenicol
BGC0001237.1|Thiolactomycin_11 # 19853 # 20653 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.744	BGC0001237.1|Thiolactomycin_11 	19853	20653	+	Loose	500	29.261	OXA-809	18.02	3006009	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATGGAGAGTCCCGACCACGGTGACGGTCCCGGCGACGCCGACGGCGCCGACGGCGGTTCCTGGATCCGCGGGTTCCACCCGGTCCCCGACCCCGCCGCCCGGCTCGTCTGCTTCCCGCACGCCGGCGGCTCCGCCAGCTTCTTCTTCCCGCTCTCGCGCGAGCTCGCGCAGCGGGGCGTCGAGGTGCTGCCGGTGCAGTACCCCGGACGGCAGGACCGGCGGGCCGAACCCAACATCCCCGACCTGGCGGTGATGGCCGACCGGGTGGCCGAGGCCCTCGCCCCCCGTTTGGACCGGCCGTTCGCGCTGTTCGGGCACAGCATGGGCGCCACCCTCGCCTACGAGGTGGCCCGCCGGGCGCAGGAGGCCGGCCGGCCGCCCGCCGCGCTCTTCGTCTCGGGGCGCCGGGCCCCGCACCGGGTCGTCGACGACGGGCTGCACCTGCTCTCGGACCGGGAGCTGGTCGAGGACATCATGGCCCTGGACGGCACGGAGTCGGGGATGTTCGGCGATCCGGAGCTGCTGGAGCTGGTCCTGCCGGCCATCCGCAGCGACTACCGGGCCGCGGAGACGTACCGGTTCGTCCCGGGACCGCGGTTGGACTGCCCGGTGCACGCGCTGACCGGGTTCTCCGACCCACGCGTATCGGTCGGCGAACTGCGCCACTGGGCCGGGCACACCGACGGTCCGTTCGAGCTCCAGGTCTTCCCGGGCGGCCACTTCTACCTCACGGACCACGCCGAGACGATCACCACGGGCATCGCCGAGCGGCTGGCCGCCGCGACGTCCGCCGCCTGA	MMESPDHGDGPGDADGADGGSWIRGFHPVPDPAARLVCFPHAGGSASFFFPLSRELAQRGVEVLPVQYPGRQDRRAEPNIPDLAVMADRVAEALAPRLDRPFALFGHSMGATLAYEVARRAQEAGRPPAALFVSGRRAPHRVVDDGLHLLSDRELVEDIMALDGTESGMFGDPELLELVLPAIRSDYRAAETYRFVPGPRLDCPVHALTGFSDPRVSVGELRHWAGHTDGPFELQVFPGGHFYLTDHAETITTGIAERLAAATSAA	MNKYFTYYVFASLFLSGCTVQHNLINDAQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKKINLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFIAWEKDMTLGEAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQLNII	97.44	gnl|BL_ORD_ID|4044|hsp_num:0	5114			30	318	cloxacillin; oxacillin; cefalotin
BGC0001237.1|Thiolactomycin_12 # 20578 # 20856 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0001237.1|Thiolactomycin_12 	20578	20856	-	Loose	400	25.409	IND-6	38.71	3002262	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGTGGGAGGCGCTCCACGCGCAGCTGATGCTCTCGCTCTGCCGCAGCGGCCGGGTGCCGGAGGCGTTGGAGGCCTACCGCCGCATCCGCGGTACGCTGGTGGCCGAGCTCGGGATGGAGCCGGGCGACCCGATCCGGATGCTCCACCGCTCGATCCTGCGGCGGGACCCGCTCCTCGACCTGCCCTGGCCCGGGGCCGCCCGTCAGGCGGCGGACGTCGCGGCGGCCAGCCGCTCGGCGATGCCCGTGGTGATCGTCTCGGCGTGGTCCGTGAGGTAG	MWEALHAQLMLSLCRSGRVPEALEAYRRIRGTLVAELGMEPGDPIRMLHRSILRRDPLLDLPWPGAARQAADVAAASRSAMPVVIVSAWSVR	MKRRIQFFMVSMMLTPLFSAQVKDFVIEPPIKKNLYIYKTFGVFGGKEYSANSVYLVTKTGVVLFDVPWEKAQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNNKGIKTYATPKTNQFLKRDGKATSTELIKPGKPYRFGGEEFVVDFLGEGHTADNVVVWFPKYKVLDGGCLVKSNSATDLGYIKEANLEQWPKTMHKLKTKYSEAVLIIPGHDEWKGGGHVEHTLELLDKK	38.49	gnl|BL_ORD_ID|538|hsp_num:0	590			189	282	
BGC0001237.1|Thiolactomycin_13 # 20956 # 21393 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.740	BGC0001237.1|Thiolactomycin_13 	20956	21393	-	Loose	400	32.7278	vanR gene in vanA cluster	27.45	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGACGCCGCAGGCGGAGAAGATCCGCTGTCTGCTGGCGCTCTTGTGCGTGAGGTCGGGAACGGTCGTCTCCAGGCAGTCCCTGCCCCACGCGCTGTGGTCGGGCACCCCGCCCCGTACGGCCCGCACCGTGTTACAGGTGTACGTGTCCAAGCTGCGCAAGTTCCTCGACGAGCACGGCGATCTGGCCGGCCATCTGGTCACCAAGCCGCACGGGTACGTCTTCGAGCTGGAGCCGGAGCGGCTGGACCTGCGCCGGTTCGACGCGCTGTCCGACGGGGAACCGGCCGCGGGCGCCCTGCCGGGCGAGCGCCCGGGCCCGGCGCCCGAGAAGGAACTGCGCCGGCTGCGCCAGAGGCGTGCGCGCTGTGGCCCGGCCCTGGCCGACCTGCGCGGGCTGCCCGCCTTCGCCGCGCTGGGGCGCGCCCTCGACGAGTAG	MTPQAEKIRCLLALLCVRSGTVVSRQSLPHALWSGTPPRTARTVLQVYVSKLRKFLDEHGDLAGHLVTKPHGYVFELEPERLDLRRFDALSDGEPAAGALPGERPGPAPEKELRRLRQRRARCGPALADLRGLPAFAALGRALDE	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	62.77	gnl|BL_ORD_ID|750|hsp_num:0	722			489	642	vancomycin; teicoplanin
BGC0001237.1|Thiolactomycin_14 # 21454 # 21549 # -1 # ID=1_14;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.500	BGC0001237.1|Thiolactomycin_14 	21454	21549	-	Loose	400	20.0162	IMP-46	42.86	3002237	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	CTGACTAACTCGTCAGCCGTCACCAAGAACAATCAAAAAATATGTGCCAGAGCCAGTTCTCAGGTGGAGTCGACACGGCGAAAAGGGGGAATGTGA	LTNSSAVTKNNQKICARASSQVESTRRKGGM	MKKLFVLCVFLLCNIATAEDSLPDLKIDKLEEGVYVHTSFEEVKGWNVVTKHGLVVLVKNDAYLIDTPITVKDTEKLVNWLVERGYKIKGSISTHFHDDSSAGIEWLNSQSIPTYASRLTNELRKKGGKPQATNSFDGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPDGLGYLGDANLEAWPKSAKILMSKYAKAKLVVSSHSEIGDTSLLKRTWEQAVKGLNESKKP	12.86	gnl|BL_ORD_ID|3613|hsp_num:0	4682			321	384	
